जॉनसन फार्माकेयर शेयर मूल्य लक्ष्य 2025, 2026 से 2030

Johnson Pharmacare Share Price Target 2025: Johnson Pharmacare, a major player in the pharmaceutical and healthcare industry, has built a reputation for providing high-quality medical solutions and innovative products.

With the global healthcare sector undergoing rapid changes due to growth in biotechnology, demand for affordable medicines, and an increased focus on preventive care – Johnson Pharmacare is well-positioned to take advantage of these trends. However, factors such as regulatory challenges, competition, and economic conditions could impact its growth.

In this detailed analysis, we will discuss in depth the key drivers, fundamentals, Shareholding patter, competitors, and expert estimates to provide a comprehensive view of Johnson Pharmacare’s stock price target for 2025 from January to December.

Whether you are an investor or simply interested in the pharmaceutical sector, this analysis provides valuable insights to guide your financial decisions.

Johnson Pharmacare Fundamental Analysis

• मार्केट कैप: ₹53.90 Cr.
• ROE: -0.35%
• प्रमाणन: -0.33%
• P/E अनुपात: 0
• P/B अनुपात: 0.95
• Div. यील्ड: 0%
• बुक वैल्यू: ₹1.03
• फेस वैल्यू: ₹1
• ईपीएस (टीटीएम): ₹0
• 52 सप्ताह उच्च: ₹1.44
• 52 सप्ताह कम: ₹0.68

यह भी पढ़ें: Johnson Pharmacare Share Price Target

Johnson Pharmacare Share Price Chart

Johnson Pharmacare Share Price Target 2025 (Prediction)

यह भी पढ़ें: जानकारी एज शेयर मूल्य लक्ष्य

Johnson Pharmacare Shareholding Pattern

• खुदरा और अन्य: 100%
• प्रमोटर: NA
• विदेशी संस्थाएँ: NA
• म्यूचुअल फंड: NA
• अन्य घरेलू संस्थानों: NA

Factors Affecting the Johnson Pharmacare Share Price

1. Launch of new pharmaceutical products: Johnson Pharmacare’s ability to introduce innovative and high-demand pharmaceutical products, such as generics, biosimilars, or specialty drugs, will be a key driver of growth. Successful launches can significantly boost revenue and investor confidence.
2. Expansion into emerging markets: Johnson Pharmacare’s strategy to expand into emerging markets, where demand for healthcare is growing rapidly, could open up new revenue sources. Success in these regions will attract investor interest and positively impact the stock price.
3. R&D investments in key therapeutic areas: Increased investments in research and development (R&D) for critical therapeutic areas such as oncology, cardiovascular diseases, and immunology can lead to breakthrough treatments. Strong R&D performance will enhance the company’s long-term growth potential.
4. Pricing pressure and competition: The pharmaceutical industry faces intense competition and pricing pressure, especially in generic drugs. Johnson Pharmacare’s ability to maintain competitive pricing while ensuring profitability will be key to sustaining stock price growth.
5. Regulatory approvals and compliance: The pharmaceutical industry is highly regulated, and Johnson Pharmacare’s stock price will depend on its ability to obtain timely approvals for new drugs and maintain compliance with global regulatory standards. Delays or issues could negatively impact growth prospects.

यह भी पढ़ें: बर्नपुर सीमेंट शेयर मूल्य लक्ष्य

Johnson Pharmacare Key Competitors/Peer Companies

1. नायका
2. विशाल मेगा मार्ट
3. ब्रेनबीज समाधान
4. Aegis रसद
5. रेडटेप
6. सेलो वर्ल्ड
7. एमएमटीसी
8. मेडप्लस हेल्थ सर्विसेज
9. पीडीएस अंतरराष्ट्रीय
10. Honasa उपभोक्ता

यह भी पढ़ें: KRN हीट एक्सचेंजर शेयर मूल्य लक्ष्य

हमारे साथ जुड़ने के लिए दिए गए किसी भी सोशल मीडिया बटन पर क्लिक करें।

अस्वीकरण: इस लेख में जानकारी केवल शैक्षिक उद्देश्यों के लिए है और इसमें उल्लिखित लक्ष्य बाजार विश्लेषकों द्वारा सुझाव दिए गए हैं। इसलिए, किसी भी कंपनी में अपने पैसे का निवेश करने से पहले, कंपनी के बारे में पूरी जानकारी प्राप्त करना और अपने वित्तीय सलाहकार से परामर्श करना अनिवार्य है।